1 completed, 1 recruiting. .
Follow Eptinezumab 100 or 300 mg ev: new trials by email Literature Review of Eptinezumab 100 or 300 mg ev trials Research Report on Eptinezumab 100 or 300 mg ev
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study) Eptinezumab 100 or 300 mg ev - Migraine | Recruiting | University of Florence | 50 | 2024-10-30 | 2026-01-21 | |
| Effectiveness and Tolerability of Eptinezumab Eptinezumab 100 or 300 mg ev - Migraine, Migraine With Aura | Completed | University of Florence | 130 | 2024-03-26 | 2026-06-11 |
Headache (2) · Migraine Disorders (2) · Pain (2) · Headache Disorders, Secondary (1) · Migraine with Aura (1) · Migraine without Aura (1)
Italy (2)